Table 10. Monte Carlo scenarios - percentage TOLAC found cost-effective.
Cost-Effectiveness Threshold | |||
---|---|---|---|
25,000 | 50,000 | 100,000 | |
Simulation description - variables varied | |||
Cerebral palsy* | 100.0 | 100.0 | 100.0 |
Five sensitive† | 68.0 | 68.5 | 69.4 |
All variables without stress urinary incontinence | 65.7 | 64.6 | 63.0 |
Six sensitive‡ | 9.0 | 5.0 | 2.9 |
Stress urinary incontinence§ | 7.8 | 5.0 | 3.2 |
All variables, costs 50-400% | 11.8 | 7.3 | 4.6 |
All variables, costs 50-150% | 11.2 | 6.8 | 4.8 |
The probability, cost and disutility of cerebral palsy
The probability of uterine rupture and successful TOLAC without a prior vaginal delivery, the cost of failed TOLAC, the cost of successful TOLAC, the cost of ERCD all without complications
The probability of uterine rupture and successful TOLAC without a prior vaginal delivery, the cost of failed TOLAC, the cost of successful TOLAC, the cost of ERCD all without complications, the total frequency of stress urinary incontinence
The probability, cost and disutility of stress urinary incontinence